Financials
- Market Capitalization 19.29 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4634 | KALA KALA BIO, Inc. - Common Stock | 0.96 USD | -11.93% | -36.42% | -64.18% | -83.45% | 17.85 M USD | ||
| 4635 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.51 USD | +0.57% | -2.23% | -22.86% | -54.12% | 18.97 M USD | ||
| 4638 | LPCN Lipocine Inc. - Common Stock | 2.36 USD | +0.43% | -5.22% | +4.42% | -18.62% | 19.46 M USD | ||
| 4641 | ALLR Allarity Therapeutics, Inc. - Common stock | 1.18 USD | +4.42% | +4.42% | -18.62% | +14.56% | 18.77 M USD |